Publication Information

{'id': 'https://openalex.org/W2043297692', 'doi': 'https://doi.org/10.1158/1538-7445.am2012-4688', 'title': 'Abstract 4688: E7449: A novel PARP inhibitor enhances the efficacy of radiotherapy and chemotherapy and has potent single agent anticancer activity in BRCA-deficient tumors', 'display_name': 'Abstract 4688: E7449: A novel PARP inhibitor enhances the efficacy of radiotherapy and chemotherapy and has potent single agent anticancer activity in BRCA-deficient tumors', 'publication_year': 2012, 'publication_date': '2012-04-01', 'ids': {'openalex': 'https://openalex.org/W2043297692', 'doi': 'https://doi.org/10.1158/1538-7445.am2012-4688', 'mag': '2043297692'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2012-4688', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5090570108', 'display_name': 'Sharon McGonigle', 'orcid': 'https://orcid.org/0000-0001-8066-0575'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sharon McGonigle', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100430134', 'display_name': 'Zhihong Chen', 'orcid': 'https://orcid.org/0000-0002-9749-2501'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zhihong Chen', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5108369477', 'display_name': 'Jiayi Wu', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Jiayi Wu', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5031053642', 'display_name': 'Karen Ackermann', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Karen Ackermann', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047113286', 'display_name': 'Karen TenDyke', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Karen Tendyke', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5043461259', 'display_name': 'George A. Moniz', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'George Moniz', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5033009316', 'display_name': 'K. Nomoto', 'orcid': 'https://orcid.org/0000-0001-9553-0685'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Kenichi Nomoto', 'raw_affiliation_strings': ['1Eisai, Inc, Andover, MA'], 'affiliations': [{'raw_affiliation_string': '1Eisai, Inc, Andover, MA', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.49, 'has_fulltext': False, 'cited_by_count': 5, 'citation_normalized_percentile': {'value': 0.670323, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 80, 'max': 81}, 'biblio': {'volume': '72', 'issue': '8_Supplement', 'first_page': '4688', 'last_page': '4688'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9971, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11914', 'display_name': 'PARP inhibition in cancer therapy', 'score': 0.9971, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10123', 'display_name': 'DNA Repair Mechanisms', 'score': 0.9614, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/parp-inhibitor', 'display_name': 'PARP inhibitor', 'score': 0.8026536}, {'id': 'https://openalex.org/keywords/parp1', 'display_name': 'PARP1', 'score': 0.78624177}, {'id': 'https://openalex.org/keywords/clonogenic-assay', 'display_name': 'Clonogenic assay', 'score': 0.70135903}, {'id': 'https://openalex.org/keywords/olaparib', 'display_name': 'Olaparib', 'score': 0.6412668}, {'id': 'https://openalex.org/keywords/temozolomide', 'display_name': 'Temozolomide', 'score': 0.5525039}, {'id': 'https://openalex.org/keywords/veliparib', 'display_name': 'Veliparib', 'score': 0.54299915}], 'concepts': [{'id': 'https://openalex.org/C2779138821', 'wikidata': 'https://www.wikidata.org/wiki/Q7118227', 'display_name': 'PARP inhibitor', 'level': 5, 'score': 0.8026536}, {'id': 'https://openalex.org/C2778480876', 'wikidata': 'https://www.wikidata.org/wiki/Q21112674', 'display_name': 'PARP1', 'level': 5, 'score': 0.78624177}, {'id': 'https://openalex.org/C117262875', 'wikidata': 'https://www.wikidata.org/wiki/Q5135057', 'display_name': 'Clonogenic assay', 'level': 3, 'score': 0.70135903}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.66283524}, {'id': 'https://openalex.org/C2779962180', 'wikidata': 'https://www.wikidata.org/wiki/Q7083106', 'display_name': 'Olaparib', 'level': 5, 'score': 0.6412668}, {'id': 'https://openalex.org/C182979987', 'wikidata': 'https://www.wikidata.org/wiki/Q3907241', 'display_name': 'Poly ADP ribose polymerase', 'level': 4, 'score': 0.5800101}, {'id': 'https://openalex.org/C143425029', 'wikidata': 'https://www.wikidata.org/wiki/Q5205747', 'display_name': 'DNA damage', 'level': 3, 'score': 0.5753464}, {'id': 'https://openalex.org/C187206112', 'wikidata': 'https://www.wikidata.org/wiki/Q3113091', 'display_name': 'Base excision repair', 'level': 4, 'score': 0.5589602}, {'id': 'https://openalex.org/C2777389519', 'wikidata': 'https://www.wikidata.org/wiki/Q425088', 'display_name': 'Temozolomide', 'level': 3, 'score': 0.5525039}, {'id': 'https://openalex.org/C134935766', 'wikidata': 'https://www.wikidata.org/wiki/Q210538', 'display_name': 'DNA repair', 'level': 3, 'score': 0.5492827}, {'id': 'https://openalex.org/C2781312401', 'wikidata': 'https://www.wikidata.org/wiki/Q7919041', 'display_name': 'Veliparib', 'level': 5, 'score': 0.54299915}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.43698946}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.43331113}, {'id': 'https://openalex.org/C207001950', 'wikidata': 'https://www.wikidata.org/wiki/Q141124', 'display_name': 'In vivo', 'level': 2, 'score': 0.40240863}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.38066116}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.34265468}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.3225856}, {'id': 'https://openalex.org/C82381507', 'wikidata': 'https://www.wikidata.org/wiki/Q416878', 'display_name': 'Polymerase', 'level': 3, 'score': 0.23066548}, {'id': 'https://openalex.org/C552990157', 'wikidata': 'https://www.wikidata.org/wiki/Q7430', 'display_name': 'DNA', 'level': 2, 'score': 0.18808925}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.089886904}, {'id': 'https://openalex.org/C2778227246', 'wikidata': 'https://www.wikidata.org/wiki/Q1365309', 'display_name': 'Glioma', 'level': 2, 'score': 0.08002108}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.058615714}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2012-4688', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.85}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4296617455', 'https://openalex.org/W3135348276', 'https://openalex.org/W3134914296', 'https://openalex.org/W3009707110', 'https://openalex.org/W2914979195', 'https://openalex.org/W2901011044', 'https://openalex.org/W2807317098', 'https://openalex.org/W2283134145', 'https://openalex.org/W2016425953', 'https://openalex.org/W2003243316'], 'abstract_inverted_index': {'Abstract': [0], 'E7449': [1, 130, 157, 173, 191, 220, 236, 271, 286, 308, 328, 354, 385], 'is': [2, 17, 92, 102, 325, 355], 'an': [3, 103], 'orally': [4], 'bioavailable,': [5], 'potent,': [6], 'small': [7], 'molecule': [8, 20], 'inhibitor': [9, 128, 363], 'of': [10, 45, 66, 71, 80, 124, 144, 152, 165, 190, 235, 268, 285, 306, 311, 378, 384, 403, 408], 'Poly(ADP-ribose)': [11], 'Polymerase': [12], '(PARP)1': [13], 'and': [14, 23, 36, 52, 76, 84, 134, 140, 147, 332, 343, 349, 358, 361, 380], 'PARP2.': [15], 'PARP1': [16, 51, 60, 133, 360], 'a': [18, 40, 95, 137, 175, 193, 201, 225, 269, 330, 356, 387], 'key': [19], 'in': [21, 42, 106, 136, 158, 174, 179, 181, 200, 224, 231, 243, 262, 275, 291, 297, 314, 329, 340, 368, 370, 386], 'sensing': [22], 'repairing': [24], 'single': [25, 96, 194, 270, 303], 'strand': [26, 47, 108], 'DNA': [27, 48, 57, 74, 81, 109], 'breaks': [28], 'via': [29], 'the': [30, 43, 64, 67, 78, 122, 125, 142, 166, 182, 211, 244, 298, 376, 404, 409], 'base': [31], 'excision': [32], 'repair': [33, 44, 75, 110], '(BER)': [34], 'pathway': [35], 'may': [37], 'also': [38, 374], 'play': [39], 'role': [41], 'double': [46, 107], 'breaks.': [49], 'Both': [50], 'PARP2': [53, 135, 362], 'are': [54], 'activated': [55], 'upon': [56], 'damage': [58], 'with': [59, 248, 336, 364], 'activity': [61, 164, 259, 277, 290, 313, 367, 377], 'accounting': [62], 'for': [63, 86, 412], 'majority': [65], 'PARP': [68, 72, 90, 127, 258, 276, 289, 312, 324, 351], 'response.': [69], 'Inhibition': [70], 'impairs': [73], 'potentiates': [77, 141, 375], 'efficacy': [79], 'damaging': [82], 'chemotherapy': [83, 381], 'radiotherapy': [85, 146, 153, 379], 'cancer': [87, 98, 216], 'treatment.': [88], 'Additionally,': [89], 'inhibition': [91, 229, 310, 342], 'effective': [93], 'as': [94, 192], 'agent': [97, 168, 195], 'therapy': [99], 'where': [100], 'there': [101], 'underlying': [104], 'defect': [105], 'by': [111, 156, 172, 327], 'homologous': [112], 'recombination': [113], '(e.g.,': [114], 'BRCA': [115], 'mutation).': [116], 'In': [117, 210], 'this': [118], 'study': [119, 390], 'we': [120], 'describe': [121], 'development': [123], 'novel': [126], 'E7449.': [129], 'potently': [131, 239], 'inhibits': [132], 'cell-free': [138], 'assay': [139, 230], 'cytotoxicity': [143], 'both': [145], 'chemotherapy.': [148], 'The': [149, 162, 273, 283], 'cytotoxic': [150], 'effect': [151, 256], 'was': [154, 170, 260, 278, 294, 317], 'enhanced': [155], 'clonogenic': [159], 'survival': [160], 'assays.': [161], 'anti-tumor': [163, 366], 'alkylating': [167], 'temozolomide': [169], 'potentiated': [171], 'dose': [176, 253, 333], 'responsive': [177, 254], 'manner': [178, 335], 'vivo': [180, 371], 'B16-F10': [183], 'melanoma': [184], 'isograft': [185], 'mouse': [186, 206], 'model.': [187, 209, 301], 'Daily': [188], 'dosing': [189], 'significantly': [196, 221], 'inhibited': [197, 222, 240, 326], 'tumor': [198, 241, 264, 292, 315], 'growth': [199, 228, 242], 'genetically': [202], 'engineered': [203], 'BRCA1': [204, 212], 'null': [205], 'ovarian': [207], 'xenograft': [208, 246, 300], 'mutant': [213], 'human': [214], 'breast': [215], 'cell': [217], 'line': [218], 'MDA-MB-436,': [219], 'proliferation': [223], 'long': [226], 'term': [227], 'vitro.': [232], 'Oral': [233], 'administration': [234, 267, 305], 'once': [237], 'daily': [238], 'MDA-MB-436': [245, 263], 'model': [247], 'no': [249], 'toxicity': [250], 'observed.': [251], 'A': [252], 'pharmacodynamic': [255], 'on': [257], 'demonstrated': [261], 'tissue': [265, 293, 316], 'following': [266], 'dose.': [272], 'decrease': [274], 'sustained': [279, 350], 'over': [280, 319], 'several': [281], 'hours.': [282], 'ability': [284], 'to': [287], 'inhibit': [288], 'further': [295], 'investigated': [296], 'H460': [299], 'Following': [302], 'oral': [304], 'various': [307], 'dosages,': [309], 'determined': [318], 'time.': [320], 'Studies': [321], 'revealed': [322], 'that': [323], 'time': [331], 'dependent': [334], 'lower': [337], 'doses': [338, 345], 'resulting': [339], 'transient': [341], 'higher': [344], 'causing': [346], 'more': [347], 'complete': [348], 'inhibition.': [352], 'Conclusion:': [353], 'potent': [357, 365], 'selective': [359], 'BRCA-deficient': [369], 'models.': [372], 'It': [373], 'pre-clinically.': [382], 'Evaluation': [383], 'Phase': [388], '1': [389], 'will': [391], 'be': [392], 'initiated': [393], 'soon.': [394], 'Citation': [395], 'Format:': [396], '{Authors}.': [397], '{Abstract': [398], 'title}': [399], '[abstract].': [400], 'In:': [401], 'Proceedings': [402], '103rd': [405], 'Annual': [406], 'Meeting': [407], 'American': [410], 'Association': [411], 'Cancer': [413, 424], 'Research;': [414], '2012': [415], 'Mar': [416], '31-Apr': [417], '4;': [418], 'Chicago,': [419], 'IL.': [420], 'Philadelphia': [421], '(PA):': [422], 'AACR;': [423], 'Res': [425], '2012;72(8': [426], 'Suppl):Abstract': [427], 'nr': [428], '4688.': [429], 'doi:1538-7445.AM2012-4688': [430]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2043297692', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}, {'year': 2014, 'cited_by_count': 1}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-08T13:03:49.673052', 'created_date': '2016-06-24'}